Details of the Drug

General Information of Drug (ID: DMACJ07)

Drug Name

AT-GAA

Indication

Disease Entry	ICD 11	Status	REF
Pompe disease	5C51.3	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Protein/peptide

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03729362) PROPEL Study - A Study Comparing ATB200/AT2221 With Alglucosidase/Placebo in Adult Subjects With LOPD. U.S. National Institutes of Health.